Abbott India (BOM:500488) Total Receivables: ₹4,886 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500488 Abbott India Ltd BOM:500488
87 GF Score
Price ₹28,275.25
GF Value ₹32,445.34
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott India Total Receivables?

Abbott India BOM:500488 +0.93% 87 Total Receivables is ₹4,886 Mil as of Mar. 2026. GuruFocus rates BOM:500488 with a GF Score™ of 87/100 and a GF Value™ of ₹32,445.34 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Abbott India's Total Receivables for the quarter that ended in Mar. 2026 was ₹4,886 Mil.

Abbott India Total Receivables Historical Data

* Premium members only.

The historical data trend for Abbott India's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India Total Receivables Chart

Abbott India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,543.80 3,815.10 3,943.60 6,515.10 4,885.80

Abbott India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,515.10 0.00 5,073.10 0.00 4,885.80
BOM:500488
87GF Score
Abbott India Ltd BOM:500488
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott India Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹4,886 Mil mean?
Abbott India (BOM:500488) has a Total Receivables of ₹4,886 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Abbott India and its competitors.
Is Abbott India's Total Receivables too high?
Abbott India's current Total Receivables is ₹4,886 Mil. Overall, Abbott India has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott India's Total Receivables compare to ZTS and UTHR?
Abbott India's Total Receivables of ₹4,886 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Abbott India and its competitors. Abbott India's current Total Receivables is ₹4,886 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott India stock overvalued right now?
Based on GuruFocus' analysis, Abbott India (BOM:500488) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹32,445.34, compared to a current price of ₹28,275.25 — trading 12.9% below its estimated fair value. The current Total Receivables is ₹4,886 Mil. Abbott India's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Abbott India (BOM:500488), the current Total Receivables is ₹4,886 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott India (BOM:500488) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott India stock appears to be undervalued. The current stock price of ₹28,275.25 is trading 12.9% below its estimated GF Value™ of ₹32,445.34. GuruFocus considers Abbott India to be Modestly Undervalued.

Key valuation signals for BOM:500488:

  • Total Receivables: ₹4,886 Mil
  • GF Value™: ₹32,445.34 vs. price of ₹28,275.25 (12.9% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the BOM:500488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott India Business Description

Other Exchanges ABBOTINDIA:India
Address Plot C-68, G Block, 16th Floor, Godrej BKC, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
87GF Score

Get the complete analysis for BOM:500488

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28,275.25
Price
₹32,445.34
GF Value